statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Journey Medical Co. (NASDAQ:DERM  Get Free Report) Director Lindsay A. Md Rosenwald acquired 10,000 shares of Journey Medical stock in a transaction that occurred on Monday, March 25th. The...

Journey Medical Co. (NASDAQ:DERM) Director Lindsay A. Md Rosenwald Acquires 10,000 Shares of Stock

Record consolidated net revenue of $84.5 million for full-year 2023 Fortress may receive up to four regulatory decisions on NDAs and BLAs in the next 18 months FDA accepted New Drug Application...

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

Director Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)

Q4 2023 Journey Medical Corp Earnings Call Transcript

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
DERM stock results show that Journey Medical beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of...

DERM Stock Earnings: Journey Medical Beats EPS, Beats Revenue for Q4 2023

Journey Medical GAAP EPS of -$0.21 misses by $0.02, revenue of $79.18M beats by $0.21M...

Journey Medical GAAP EPS of -$0.21 misses by $0.02, revenue of $79.18M beats by $0.21M

Company generated total revenues of $79.2 million for the full year ended December 31, 2023, a 7% increase from the $73.7 million reported in 2022 Achieved $15.6 million in operating cost...

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Journey Medical Earnings Preview

Journey Medical (NASDAQ:DERM) render noti i prossimi risultati degli utili gioved 21 marzo. Ecco la guida di Benzinga con tutte le informazioni pi importanti per la pubblicazione degli utili.
Cosa...

Anteprima degli utili: Journey Medical

Journey Medical (NASDAQ:DERM) anuncia su pr xima ronda de ganancias este jueves, 21 de marzo. Esta es la gu a de Benzinga con la informaci n m s importante para esta presentaci n de resultados del...

Avance: ganancias de Journey Medical

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Watchers	2,847
52-Wk Low	$1.02
52-Wk High	$8.11

Volume	15,113.00
52-Wk High	$8.11
52-Wk Low	$1.02

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.24	--	--	N/A
Q4'23	-$0.09	-$0.59	-594.12%	MISSED
Q3'23	-$0.16	$0.99	738.71%	BEAT
Q2'23	-$0.34	-$0.04	88.06%	BEAT
Q1'23	-$0.45	-$0.57	-27.61%	MISSED

DERM Journey Medical Corp

About

Feed

News

Earnings

Fundamentals